Rchr
J-GLOBAL ID:202101021038347820   Update date: Jan. 30, 2024

Sato Hiroko

サトウ ヒロコ | Sato Hiroko
Affiliation and department:
Research field  (2): Fetal medicine/Pediatrics ,  Hematology and oncology
Research theme for competitive and other funds  (3):
  • 2023 - 2027 思春期がん患者の自己理解と自己表現スキルを促進する復学支援ツールの開発
  • 2015 - 2018 Pathomechanism of neonatal hyperbilirubinemia: the relationship between genetics and nutrition
  • 2013 - 2015 Pathomechanism of neonatal hyperbilirubinemia: the relationship between genetics and nutrition
Papers (4):
  • Tetsuo Mitsui, Satoshi Makino, Gen Tamiya, Hiroko Sato, Yuki Kawakami, Yoshitaka Takahashi, Toru Meguro, Hiroko Izumino, Yosuke Sudo, Ikuo Norota, et al. ALOX12 mutation in a family with dominantly inherited bleeding diathesis. Journal of Human Genetics. 2021. 66. 8. 753-759
  • Hiroko Sato, Naomi Kawasaki, Motoi Kawasaki, Yu Abiko, Toru Meguro, Noriyuki Takahashi, Hiroko Izumino, Miyako Kanno, Chikahiko Numakura, Ayako Sasaki, et al. Three Consecutive Cases of Familial Hemophagocytic Lymphohistiocytosis, Including a Case Due to Maternal Uniparental Disomy. Journal of Pediatric Hematology/Oncology. 2020. 42. 8. e819-e821
  • Hiroko Sato, Toshihiko Uchida, Kentaro Toyota, Tomohiro Nakamura, Gen Tamiya, Miyako Kanno, Taeko Hashimoto, Masashi Watanabe, Kuraaki Aoki, Kiyoshi Hayasaka. Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms. Journal of Human Genetics. 2015. 60. 1. 35-40
  • Hiroko Sato, Toshihiko Uchida, Kentaro Toyota, Miyako Kanno, Taeko Hashimoto, Masashi Watanabe, Tomohiro Nakamura, Gen Tamiya, Kuraaki Aoki, Kiyoshi Hayasaka. Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. Journal of Human Genetics. 2013. 58. 1. 7-10
Education (1):
  • 2001 - 2007 山形大学 医学部 医学科
Committee career (1):
  • 2019/04 - 現在 JCCG 胚細胞腫瘍委員会 委員
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page